These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36244543)

  • 21. Synthesis, structure-activity, and structure-stability relationships of 2-substituted-N-(4-oxo-3-oxetanyl) N-acylethanolamine acid amidase (NAAA) inhibitors.
    Vitale R; Ottonello G; Petracca R; Bertozzi SM; Ponzano S; Armirotti A; Berteotti A; Dionisi M; Cavalli A; Piomelli D; Bandiera T; Bertozzi F
    ChemMedChem; 2014 Feb; 9(2):323-36. PubMed ID: 24403170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Potent Systemically Active N-Acylethanolamine Acid Amidase Inhibitor that Suppresses Inflammation and Human Macrophage Activation.
    Ribeiro A; Pontis S; Mengatto L; Armirotti A; Chiurchiù V; Capurro V; Fiasella A; Nuzzi A; Romeo E; Moreno-Sanz G; Maccarrone M; Reggiani A; Tarzia G; Mor M; Bertozzi F; Bandiera T; Piomelli D
    ACS Chem Biol; 2015 Aug; 10(8):1838-46. PubMed ID: 25874594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation.
    Solorzano C; Zhu C; Battista N; Astarita G; Lodola A; Rivara S; Mor M; Russo R; Maccarrone M; Antonietti F; Duranti A; Tontini A; Cuzzocrea S; Tarzia G; Piomelli D
    Proc Natl Acad Sci U S A; 2009 Dec; 106(49):20966-71. PubMed ID: 19926854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corrigendum to "N-acylethanolamine acid amidase (NAAA) exacerbates psoriasis inflammation by enhancing dendritic cell (DCs) maturation" [Pharm. Res. 185 (2022) 1-16/YPHRS_106491].
    Li Y; Li Y; Xu S; Chen Y; Zhou P; Hu T; Li H; Liu Y; Xu Y; Ren J; Qiu Y; Lu C
    Pharmacol Res; 2022 Nov; 185():106527. PubMed ID: 36328902
    [No Abstract]   [Full Text] [Related]  

  • 25. Synthesis and structure-activity relationships of N-(2-oxo-3-oxetanyl)amides as N-acylethanolamine-hydrolyzing acid amidase inhibitors.
    Solorzano C; Antonietti F; Duranti A; Tontini A; Rivara S; Lodola A; Vacondio F; Tarzia G; Piomelli D; Mor M
    J Med Chem; 2010 Aug; 53(15):5770-81. PubMed ID: 20604568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity-Based Probe for N-Acylethanolamine Acid Amidase.
    Romeo E; Ponzano S; Armirotti A; Summa M; Bertozzi F; Garau G; Bandiera T; Piomelli D
    ACS Chem Biol; 2015 Sep; 10(9):2057-2064. PubMed ID: 26102511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lysosome targeting fluorescent probe for NAAA imaging and its applications in the drug development for anti-inflammatory.
    Zhou L; Tian M; Zhang B; Cao X; Huo X; Yang F; Cao P; Feng L; Ma X; Tian X
    Int J Biol Macromol; 2024 Apr; 263(Pt 2):130307. PubMed ID: 38382784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis.
    Alhouayek M; Bottemanne P; Subramanian KV; Lambert DM; Makriyannis A; Cani PD; Muccioli GG
    FASEB J; 2015 Feb; 29(2):650-61. PubMed ID: 25384424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different roles for the acyl chain and the amine leaving group in the substrate selectivity of
    Ghidini A; Scalvini L; Palese F; Lodola A; Mor M; Piomelli D
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1411-1423. PubMed ID: 34256657
    [No Abstract]   [Full Text] [Related]  

  • 30. Targeting NAAA counters dopamine neuron loss and symptom progression in mouse models of parkinsonism.
    Palese F; Pontis S; Realini N; Torrens A; Ahmed F; Assogna F; Pellicano C; Bossù P; Spalletta G; Green K; Piomelli D
    Pharmacol Res; 2022 Aug; 182():106338. PubMed ID: 35781057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of N-acylethanolamine acid amidase reduces nicotine-induced dopamine activation and reward.
    Sagheddu C; Scherma M; Congiu M; Fadda P; Carta G; Banni S; Wood JT; Makriyannis A; Malamas MS; Pistis M
    Neuropharmacology; 2019 Jan; 144():327-336. PubMed ID: 30439418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N-acylethanolamine-hydrolyzing acid amidase and fatty acid amide hydrolase inhibition differentially affect N-acylethanolamine levels and macrophage activation.
    Alhouayek M; Bottemanne P; Makriyannis A; Muccioli GG
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 May; 1862(5):474-484. PubMed ID: 28065729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous molecules stimulating N-acylethanolamine-hydrolyzing acid amidase (NAAA).
    Tai T; Tsuboi K; Uyama T; Masuda K; Cravatt BF; Houchi H; Ueda N
    ACS Chem Neurosci; 2012 May; 3(5):379-85. PubMed ID: 22860206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-acylethanolamine-hydrolysing acid amidase: A new potential target to treat paclitaxel-induced neuropathy.
    Toma W; Caillaud M; Patel NH; Tran TH; Donvito G; Roberts J; Bagdas D; Jackson A; Lichtman A; Gewirtz DA; Makriyannis A; Malamas MS; Imad Damaj M
    Eur J Pain; 2021 Jul; 25(6):1367-1380. PubMed ID: 33675555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibiting immunoregulatory amidase NAAA blocks ZIKV maturation in Human Neural Stem Cells.
    Lai M; La Rocca V; Iacono E; Filipponi C; De Carli A; Favaro D; Fonnesu R; Filippini F; Spezia PG; Amato R; Catelli E; Matteo B; Lottini G; Onorati M; Clementi N; Freer G; Piomelli D; Pistello M
    Antiviral Res; 2023 Aug; 216():105664. PubMed ID: 37414288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and In Vivo Use of an Activity-based Probe for N-acylethanolamine Acid Amidase.
    Romeo E; Pontis S; Ponzano S; Bonezzi F; Migliore M; Di Martino S; Summa M; Piomelli D
    J Vis Exp; 2016 Nov; (117):. PubMed ID: 27911411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NAAA-regulated lipid signaling in monocytes controls the induction of hyperalgesic priming in mice.
    Fotio Y; Mabou Tagne A; Squire E; Lee HL; Phillips CM; Chang K; Ahmed F; Greenberg AS; Villalta SA; Scarfone VM; Spadoni G; Mor M; Piomelli D
    Nat Commun; 2024 Feb; 15(1):1705. PubMed ID: 38402219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, biological evaluation, and structure activity relationship (SAR) study of pyrrolidine amide derivatives as
    Zhou P; Xiang L; Zhao D; Ren J; Qiu Y; Li Y
    Medchemcomm; 2019 Feb; 10(2):252-262. PubMed ID: 30931090
    [No Abstract]   [Full Text] [Related]  

  • 39. Second-Generation Non-Covalent NAAA Inhibitors are Protective in a Model of Multiple Sclerosis.
    Migliore M; Pontis S; Fuentes de Arriba AL; Realini N; Torrente E; Armirotti A; Romeo E; Di Martino S; Russo D; Pizzirani D; Summa M; Lanfranco M; Ottonello G; Busquet P; Jung KM; Garcia-Guzman M; Heim R; Scarpelli R; Piomelli D
    Angew Chem Int Ed Engl; 2016 Sep; 55(37):11193-11197. PubMed ID: 27404798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of triple negative breast cancer-associated inflammation and progression by N- acylethanolamine acid amide hydrolase (NAAA).
    Benchama O; Malamas MS; Praveen K; Ethier EC; Williams MK; Makriyannis A; Avraham HK
    Sci Rep; 2022 Dec; 12(1):22255. PubMed ID: 36564457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.